To determine the expression patterns of REST in adenocarcinoma and neuroendocrine prostate cancer (NEPC), we analyzed its expression patterns in a panel of androgen-dependent prostate cancer and NEPC cell lines, and patient samples. Here, REST is linked to prostate carcinoma.